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a  b  s  t  r  a  c  t
Telomere  length  is  hypothesised  to  be  a  biological  marker  of  both  cognitive  and physical  ageing.  Here
we  measure  telomere  length,  and  cognitive  and  physical  abilities  at mean  ages 70,  73  and  76  years  in
the  Lothian  Birth  Cohort  1936  (LBC1936),  and  at mean  ages  79, 87,  90 and  92 years  in the  Lothian  Birth
Cohort  1921  (LBC1921).  We  investigate  whether  telomere  length  change  predicts  change  in cognitivevailable online 10 February 2016
eywords:
elomeres
ognition
ognitive ageing
and  physical  abilities.  In LBC1936  telomere  length  decreased  by an  average  of 65 base  pairs  per  year
and in LBC1921  by 69 base  pairs  per  year.  However,  change  in telomere  length  did  not  predict  change
in  cognitive  or physical  abilities.  This  study  shows  that,  although  cognitive  ability,  walking  speed,  lung
function  and grip  strength  all decline  with  age,  they do so  independently  of  telomere  length  shortening.
©  2016  The  Authors.  Published  by  Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the  CC  BY
hysical ageing
. Introduction
Determining the biological factors that influence both cognitive
nd physical decline in later life is an important challenge fac-
ng researchers today (Blazer et al., 2015; den Ouden et al., 2011).
elomeres are nucleo-protein complexes at the end of eukaryotic
hromosomes. They protect the ends of chromosomes, but shorten
ach time a somatic cell replicates (Harley et al., 1990; Lindsey
t al., 1991). Environmental factors also contribute to accelerated
ecline in telomere length. These include low socio-economic sta-
us, smoking, oxidative stress, and psychological stress (Valdes
t al., 2005; von Zglinicki, 2002; Robertson et al., 2013). Telom-
re length decreases with age and a systematic review determined
hat the correlation between telomere length and chronological age
s about −0.3 (Muezzinler et al., 2013). Leukocyte telomere length
∗ Corresponding author at: University of Edinburgh, Centre for Cognitive Age-
ng and Cognitive Epidemiology, 7 George Square, Edinburgh EH8 9JZ, UK.
ax: +44 131 651 1771.
E-mail address: Sarah.Harris@igmm.ed.ac.uk (S.E. Harris).
ttp://dx.doi.org/10.1016/j.mad.2016.02.004
047-6374/© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access license  (http://creativecommons.org/licenses/by/4.0/).
has previously been associated with a number of traits and dis-
eases in older age including cognitive abilities (Harris et al., 2006,
2012; Yaffe et al., 2009; Der et al., 2012; Ma  et al., 2013), dementia
(Grodstein et al., 2008; Martin-Ruiz et al., 2006; Panossian et al.,
2003; von Zglinicki et al., 2000), physical health (Gardner et al.,
2013; Woo  et al., 2014; Masi et al., 2014; Baylis et al., 2014) and
obesity (Valdes et al., 2005; Njajou et al., 2012), and has been
hypothesised to be a biological marker of ageing (von Zglinicki and
Martin-Ruiz, 2005). However, a systematic review concluded that
current results were equivocal and that more studies, including lon-
gitudinal studies, were required that assessed telomere length and
ageing-related functional measures (Mather et al., 2011). Longitu-
dinal studies have the potential to measure age-related decline in
telomere length, and cognitive and physical abilities more accu-
rately than cross-sectional studies and also allow the investigation
of the change of multiple variables in parallel with each other.
There are many studies that show lower childhood cognitive
ability is associated with poorer health and more illness in adult-
hood and older age, and to earlier mortality from all causes and from
several specific causes, such as cardiovascular disease (Deary et al.,
article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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2010). Early life IQ has previously been associated with telomere
length in midlife (Schaefer et al., 2015). The mechanism of the child-
hood cognition-illness/death association is not understood, but it is
possible that telomeres might provide a biomarker of how lifestyle
has affected the body.
We previously reported mostly-null cross-sectional associa-
tions between telomere length and cognitive function, walking
speed, lung function, and grip strength in the Lothian Birth Cohorts
of 1921 and 1936 (LBC1921 and LBC1936) (Harris et al., 2006,
2012). More recently, we  showed that the same cognitive and phys-
ical abilities decline on average between ages 70 and 76 years
in LBC1936 (Marioni et al., 2015). Here, we report longitudinal
analyses investigating whether decline in telomere length pre-
dicts cognitive and physical decline in the Lothian Birth Cohorts.
We  also investigate whether baseline telomere length influences
subsequent decline in cognitive and physical abilities. Finally, we
test whether cognitive ability measured in childhood is related to
telomere length decline in later life.
2. Materials and methods
2.1. Lothian Birth Cohort 1936 (LBC1936)
LBC1936 consists of 1091 (548 men  and 543 women) surviving
members of the Scottish Mental Survey of 1947 (Scottish Council
for Research in Education, 1949). At approximately age 11 years
most took a valid mental ability test, the Moray House Test version
12 (MHT). At a mean age of 69.5 years (SD 0.8) they were recruited
to a study to determine influences on cognitive ageing (Deary et al.,
2007, 2012a). They underwent a series of cognitive and physi-
cal tests. Two  further waves of cognitive and physical tests have
occurred at mean ages 73 and 76 years. DNA was extracted from
peripheral blood leukocytes at ages 70, 73 and 76 years from which
telomere length was measured. Cognitive tests taken at each of the
three waves included six Wechsler Adult Intelligence Scale-IIIUK
(WAIS-III) (Wechsler, 1998) non-verbal subtests (matrix reason-
ing, letter number sequencing, block design, symbol search, digit
symbol, and digit span backward). From these six cognitive tests
a general fluid cognitive factor (gf) was derived. The scores from
the first unrotated component of a principal components analy-
sis were extracted and labelled as gf. This component explained
52% of the variance, with individual test loadings ranging between
0.65 and 0.72. Physical trait measures included time taken to walk
six metres at normal pace, grip strength measured with a Jamar
Hydraulic Hand Dynamometer (all subjects had three trials with the
dominant hand; the best of the three trials was  used), and forced
expiratory volume from the lungs in one second (FEV1) measured
using a microspirometer (the best of the three trials was used).
2.2. Lothian Birth Cohort 1921 (LBC1921)
LBC1921 consists of 550 (234 men  and 316 women) surviving
members of the Scottish Mental Survey of 1932 (Scottish Council for
Research in Education, 1933). At approximately age 11 years most
took a valid mental ability test, the MHT. At a mean age of 79.1 years
(SD 0.6) they were recruited to a study to determine influences
on cognitive ageing (Deary et al., 2004, 2012b). They underwent a
series of cognitive and physical tests. Four further waves of cogni-
tive and physical tests have occurred at mean ages 83, 87, 90 and
92 years. DNA was extracted from peripheral blood leukocytes at
ages 79, 87, 90 and 92 years from which telomere length was  mea-
sured. Cognitive tests taken at each of these four waves included
Raven’s Progressive Matrices (Raven et al., 1977), Verbal Fluency
(Lezak, 1995) and Logical Memory (Wechsler, 1987). From these
three cognitive tests a general fluid cognitive factor (gf) was  derived
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using principal component analysis. The scores from the first unro-
tated component were extracted and labelled as gf. This component
explained 53% of the variance, with individual test loadings rang-
ing between 0.65 and 0.73. Physical trait measures included time
taken to walk six metres at normal pace, grip strength measured
with a Jamar Hydraulic Hand Dynamometer (all subjects had three
trials with the dominant hand; the best of the three trials was used)
and forced expiratory volume from the lungs in one second (FEV1)
measured using a microspirometer (the best of the three trials was
used).
Ethics permission for the LBC1936 was obtained from the
Multi-Centre Research Ethics Committee for Scotland (Wave 1:
MREC/01/0/56), the Lothian Research Ethics Committee (Wave 1:
LREC/2003/2/29), and the Scotland A Research Ethics Committee
(Waves 2 and 3: 07/MRE00/58). Ethics permission for the LBC1921
was obtained from the Lothian Research Ethics Committee (Wave
1: LREC/1998/4/183; Wave 3:1702/98/4/183) and the Scotland A
Research Ethics Committee (Waves 4 and 5:10/S1103/6). All per-
sons gave their informed consent prior to their inclusion in the
study.
2.3. Telomere length measurement
DNA was extracted from whole blood by standard procedures
at the Wellcome Trust Clinical Research Facility Genetics Core at
the Western General Hospital, Edinburgh. Telomere length was
measured using a quantitative real-time polymerase chain reaction
(PCR) assay (Martin-Ruiz et al., 2004). The intra-assay coefficient
of variation was  2.7% and the inter-assay coefficient of variation
was 5.1%. Four internal control DNA samples were run within
each plate to generate absolute telomere lengths and to correct
for plate to plate variation. These internal controls are cell lines of
known absolute telomere length, 6.9 kb, 4.03 kb, 2.0 kb and 1.32 kb
respectively, whose relative ratio values (telomere starting quan-
tity/glyceraldehyde 3-phosphate dehydrogenase starting quantity)
were used to generate a regression line by which values of relative
telomere length for the actual samples were converted into abso-
lute telomere lengths. The correlation between relative telomere
length and absolute telomere length was 0.8. Measurements were
performed in quadruplicate and the mean of the measurements
used. PCRs were performed on an Applied Biosystems (Pleasonton,
CA, USA) 7900HT Fast Real Time PCR machine.
2.4. Statistical analyses
Linear mixed models were used to determine if telomere length
and cognitive and physical abilities changed over time. One indi-
vidual with chronic lymphocytic leukaemia was removed from the
LBC1936 analyses. Covariates included age (centred at the min-
imum value) as the time scale, sex, for telomere length white
blood cell counts (lymphocyte, basophil, neutrophil, eosinophil and
monocyte) and for physical abilities height. Individual participant
number was included as a random effect. Baseline telomere length
was added as a fixed effect interaction with age to test if it predicted
decline in cognitive and physical abilities. Age 11 MHT score (cor-
rected for age at time of testing and sex) was then added as a fixed
effect interaction with age to test if it predicted decline in telomere
length. In LBC1921, linear regression was used to determine if age
11 MHT  score was  associated with telomere length at age 79 years.
Linear mixed models were then used to investigate if telomere
length change predicted change in cognitive and physical abili-
ties. Again covariates included age (centred at the minimum value)
as the time scale, sex, white cell counts and for physical abilities
height. Individual participant number was included as a random
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ffect. Linear mixed models were performed in R using the lme4
nd lmerTest packages (Kuznetsova et al., 2013; Bates et al., 2013).
. Results
Descriptive statistics for telomere length, general fluid cognitive
bility (gf), time taken to walk six metres, forced expiratory volume
n one second (FEV1) and grip strength for LBC1936 waves 1 (age
70 years), 2 (age ∼73 years) and 3 (age ∼79 years) are shown in
able 1, and for LBC1921 waves 1 (age ∼79 years), 3 (age ∼87 years),
 (age ∼90 years) and 5 (age ∼92 years) are shown in Table 2.
In LBC1936, mean telomere length decreased with age.
n LBC1921, mean telomere length remained relatively stable
etween ages 79 and 87 years and then decreased with age. In both
ohorts gf, FEV1 and grip strength all decreased with age and time
aken to walk six metres increased. Mean age, telomere length and
EV1 did not differ between all individuals who participated in a
articular wave of testing and those who returned for later waves
f testing. Individuals who returned for further waves of testing
enerally had a slightly higher gf, a faster walk time and a stronger
rip strength on the first occasion of testing.
Mean trajectory plots for change in telomere length, gf, six metre
alk time, FEV1, and grip strength for LBC1936 and LBC1921 are
hown in Fig. 1.
In LBC1936, a linear mixed model indicated that telomere length
ecreased by 64.8 base pairs (bp) per year (p < 2 × 10−16), which
s 1.5% of the mean telomere length at age 70 years. Telom-
res were 177.9 bp longer in males than females (p = 4.66 × 10−7).
elomere length decreased with increasing lymphocyte cell count
p = 9.5 × 10−4), but was not associated with any other white blood
ell count. As previously shown27, gf decreased by 0.05 standard
eviations per year, 6 m walk time increased by 0.15 s per year,
EV1 decreased by 0.05 L per year, and grip strength decreased by
.04 kg per year (all p values < 2 × 10−16). There was no evidence to
uggest that baseline telomere length was associated with trajec-
ory of decline in cognitive and physical abilities (all p-values > 0.2).
ge 11 Moray House Test (MHT) score was not linked to differences
n change in telomere length (p = 0.88).
In LBC1921, a linear mixed model indicated that telomere length
ecreased by 69.3 bp per year (p < 2 × 10−16), which is 1.7% of the
ean telomere length at age 79 years. Telomeres were 256.9 bp
onger in males than females (p = 1.2 × 10−8). Telomere length was
ot associated with white blood cell counts (all p values > 0.05).
f decreased by 0.05 standard deviations per year, 6 m walk time
ncreased by 0.27 s per year, FEV1 decreased by 0.03 L per year, and
rip strength decreased by 0.74 kg per year (all p values < 2 × 10−16).
aseline telomere length was not associated with decline in cogni-
ive or physical abilities (all p-values > 0.1). Age 11 Moray House
est (MHT) score was linked to the amount of telomere length
hange such that, for a standard deviation increase in age 11 cog-
itive ability score, there was a 9.7 bp greater decrease in telomere
ength per year (p = 0.044). Age 11 MHT  score was not associated
ith telomere length at age 79 years (p = 0.79).
In LBC1936 and LBC1921 there was no evidence to suggest that
ifferences in telomere length change correlated with differences in
hange in cognitive or physical abilities (all p-values > 0.1) (Table 3).
. Discussion
This study indicates that, in both LBC1936 and LBC1921, mean
elomere length decreased by ∼65 bp per year, which is just under
% of the mean telomere length at baseline. This is slightly higher
han that reported for other longitudinal studies, which ranged
rom 32 to 46 bp per year (Muezzinler et al., 2013). Cognitive and
hysical abilities also decreased during this period. Telomere lengthnd Development 154 (2016) 43–48
at baseline was not associated with decline in cognitive or physi-
cal abilities between the ages of 70 and 76 (LBC1936), or 79 and 92
(LBC1921) years. In LBC1921 childhood cognitive ability was linked
to the amount of telomere length change such that, individuals with
a higher childhood cognitive ability underwent a greater decrease
in telomere length per year in later life. The rate of decrease in
telomere length did not correlate with the rate of decrease in cog-
nitive and physical abilities in either cohort.
As far as we  aware this is the first longitudinal study, measuring
at least three time points, to investigate if telomere length decline
is associated with cognitive and physical decline. A recent meta-
analysis based on two  time points also found little evidence for
telomere length decline as biomarker for physical decline (Gardner
et al., 2013). Our results largely agree with previously published
cross-sectional findings that telomere length does not associate
with cognitive and physical ability (Yaffe et al., 2009; Harris et al.,
2012; Bendix et al., 2011). The results confirm the conclusions
from a number of previous papers that telomere length is not
informative as a biomarker for multiple dimensions of age-related
risks including cognitive decline, multi-morbidity and mortality
(Cawthon et al., 2003; Martin-Ruiz et al., 2005, 2011). In LBC1936
and LBC1921, telomere length was longer in males than in females,
which contradicts many previous studies (Gardner et al., 2014).
However, this may  reflect the fact that life-expectancy of women
is higher than men. Due to the older-age range of the Lothian Birth
Cohorts, the men are typically much healthier than those of a sim-
ilar age in the general population, whereas the women may  be
more representative of women  of a similar age in the general pop-
ulation (Harris et al., 2012). Also a meta-analysis study looking at
different methods of measuring telomere length concluded that
only the Southern blot method generates results where women
have longer telomeres than men  (Gardner et al., 2014). Interest-
ingly, mean telomere length at age 79 years in LBC1921 (4.1 kb)
was longer than mean telomere age at age 76 years in LBC1936
(3.7 kb). This may  be due to the selection of relatively healthier
participants into a study at age 79 years (Deary et al., 2012a) com-
pared to those aged 76 years who were already involved in a study.
However, the physical ability data does not support this theory e.g.,
mean grip strength at age 79 years in LBC1921 (26.5 kg) was  less
than mean grip strength in LBC1936 at age 76 years (27.9 kg). Also,
a recent study showed that although there is a negative correlation
between age and telomere length up to age 75 years, after 75 years
the correlation becomes positive (Lapham et al., 2015).
In LBC1936 higher lymphocyte count was  associated with
shorter telomeres, indicating that white blood cell distribution may
be a predictor of telomere length, as shown previously (Glei et al.,
2015). In LBC1921, age 11 cognitive ability was linked to telomere
length change such that individuals with a higher Moray House Test
score at age 11 years showed a greater decline in telomere length
in later life. This was  not due to individuals with higher age 11 cog-
nitive ability scores having longer telomeres at age 79 years. Age 11
cognitive ability scores did not influence telomere length change in
LBC1936 and the significant result in LBC1921 may be due to type
1 error. Therefore, this finding needs replicating in another study
before being considered further.
Strengths of this study include the longitudinal nature, with
measurements at three and four time points of the telomeres and
the cognitive and physical abilities in two  narrow-age cohorts
whose combined age periods range from 70 to 92 years. A further
strength is that our absolute values of telomere length were gen-
erated using four internal controls which are cell lines of known
absolute telomere length, whose relative ratio values were used
to generate a regression line by which values of relative telom-
ere length for the actual samples were converted into absolute
telomere lengths. This allowed us to accurately correct for plate to
plate variations as it is well known that the quantitative real-time
S.E. Harris et al. / Mechanisms of Ageing and Development 154 (2016) 43–48 47
Fig. 1. Mean trajectory plots for change in telomere length, general cognitive ability (gf) six metre walk time, forced expiratory volume in 1 s (FEV1), and grip strength for (a)
LBC1936 and (b) LBC1921.
Table 3
Effect of change in telomere length on change in cognitive and physical abilities. gf = general cognitive ability, FEV1 = forced expiratory volume in one second.
LBC1936 LBC1921
Beta 95% CI P Beta 95% CI P
gf −1.7 × 10−3 −8 × 10−3–0.01 0.74 0.0011 −0.02–0.02 0.91
−3
P
l
s
s
t
n
a
i
s
i
I6  m walk time (s) 6.2 × 10 −0.02–0.03 
FEV1 (L) 2.0 × 10−3 −4 × 10−3–8 × 10−3
Grip  strength (Kg) −0.03 −0.1–0.07 
CR assay method is sensitive to efficiency variations between very
ong or very short telomere amplifications. PCR efficiency is not the
ame for samples with long telomeres compared to samples with
hort telomeres. A disadvantage of the study is the relatively short
ime period between each wave of testing. As with all longitudi-
al studies, there was attrition, though the statistical method used
ll the available data. Selection bias due to differential mortality
s a common limitation in longitudinal studies. However, in this
tudy baseline telomere length and FEV1 did not differ between
ndividuals who did and did not return for later waves of testing.
ndividuals who returned for further waves of testing generally had0.59 0.010 −0.06–0.08 0.78
0.50 0.0029 −4 × 10−3–0.01 0.43
0.47 −0.035 −0.1–0.07 0.53
a slightly higher gf, a faster walk time and a stronger grip strength
on the first occasion of testing, indicating some selection bias. This
may  reduce the power of the study to detect associations between
telomere length shortening and cognitive and physical decline. A
further limitation of the study is that the sample sizes of the cohorts,
particularly at later waves, is perhaps not large enough to detect
a correlation between telomere length shortening and decline in
cognitive and physical abilities. The relative health of the cohorts
also reduces the variance of the cognitive and physical phenotypes
relative to the general population.
4 eing a
5
i
t
i
a
A
t
C
p
w
R
t
b
C
a
a
C
c
U
R
B
d
H
L
V
v
R
M
H
Y
D
H
M
G
M
P
v8 S.E. Harris et al. / Mechanisms of Ag
. Conclusion
We  find that, although telomere length, and cognitive and phys-
cal abilities all show mean decline with age in LBC1936 from age 70
o 76, and in LBC1921 from age 79 to 92, the shortening of telomeres
s independent from the observed decline in cognitive and physical
bilities.
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